Global Team Science Award
The Global Team Science Award ($3 million over 3 years) supports interdisciplinary, collaborative, and highly synergistic projects that push the boundaries of innovation and bridge research and clinical efforts in lupus. The successful Teams will focus on unraveling human lupus heterogeneity by applying cutting-edge technologies to address critical questions that could bring about breakthroughs in lupus care, research or drug development.
The 2025 deadline for this program has passed.
Inquiries can be directed to:
Scientific: Mara Lennard Richard, PhD; mrichard@lupusresearch.org
Administrative: Diomaris Gonzalez; dgonzalez@lupusresearch.org
Mechanistic Clinical Award
The LRA has established the Mechanistic Clinical Award to advance a precision framework for therapeutic development in lupus with the goal of testing novel biomarkers, therapeutic or lifestyle approaches, or mechanistic hypotheses for proof-of-principle and evaluation of the approach. The award provides up to either $500,000 over two years for mechanistic studies using lupus patient biospecimens or $1,000,000 over three years for small mechanistic clinical trials not exceeding 20 participants and two to three study sites. Clinical trials funded through this mechanism should pursue hypothesis-driven approaches and those not readily undertaken by conventional, industry-sponsored drug development trials.
The 2025 deadline for this program has passed.
Inquiries can be directed to:
Scientific: Kari Fischer, PhD; kfischer@lupusresearch.org
Administrative: Diomaris Gonzalez; dgonzalez@lupusresearch.org
Translational Bridge Award
The Translational Bridge Award ($450,000 over 2 years) provides funding to bridge the gap between post-discovery and pre-commercial development and to accelerate the pace at which promising LRA-funded foundational research discoveries are translated into clinical evaluation and transitioned to a viable product that impacts patients directly. All projects should advance potential commercial entities or clinical products with a clear and direct relevance to people with lupus and offer the potential to improve diagnosis or standard of care for the disease or usher in a cure. These can include a range of technologies, therapies, interventions, and diagnostics.
The 2024 deadline for this program has passed.
Click here for Frequently Asked Questions
Inquiries can be directed to:
Scientific: Maya Bader, PhD; mbader@lupusresearch.org
Administrative: Diomaris Gonzalez; dgonzalez@lupusresearch.org
Targeted Research Program on Engineered Cell Therapies for Lupus
The Targeted Research Program on Engineered Cell Therapies for Lupus is a dedicated funding mechanism for projects that advance the development of next-generation engineered cell therapies with a clear and direct relevance to people with lupus. The award provides up to either $300,000 over two years for pre-clinical studies, including discovery and translational projects, or $600,000 over two years for ancillary studies to ongoing or completed engineered cell therapy clinical trials for lupus. All proposals should be centered around a well-defined translation plan to advance the project to the next development stage.
The 2024 deadline for this program has passed.
Inquiries can be directed to:
Scientific: Maya Bader, PhD; mbader@lupusresearch.org
Administrative: Diomaris Gonzalez; dgonzalez@lupusresearch.org
Lupus Innovation Award
The Lupus Innovation Award ($300,000 over 2 years) provides support for pioneering, high-risk, high-reward approaches to major challenges in lupus research. Special emphasis is placed on lupus studies exploring fundamental mechanisms, novel targets and pathways, novel technologies, and interdisciplinary approaches. Both early career and established investigators new to lupus with highly innovative ideas are encouraged to apply.
The 2025 deadline for this program has passed.
Inquiries can be directed to:
Scientific: Mara Lennard Richard, PhD; mrichard@lupusresearch.org
Administrative: Diomaris Gonzalez; dgonzalez@lupusresearch.org
LRA/RRF Empowering Lupus Research Scientist Development Award
The LRA/RRF Empowering Lupus Research Scientist Development Award (up to $225,000, 3 Years (2 years guaranteed funding with possible renewal in year 3) is a mentored career development award is designed for individuals in the early stages of their career or those without significant prior research experience. Projects should help awardees generate scientific data and develop innovative research ideas necessary to transition to an independent research role in areas aligned with the stated goals of the LRA/RRF Empowering Lupus Research Partnership. Visit https://www.rheumresearch.org/career-development-research-awards#SDA for more information.
Inquiries can be directed to:
Scientific: Mara Lennard Richard, PhD; mrichard@lupusresearch.org
Administrative: Diomaris Gonzalez; dgonzalez@lupusresearch.org
LRA/RRF Empowering Lupus Research Investigator Award
The LRA/RRF Empowering Lupus Research Investigator Award (up to $500,000, 4 Years (3 years guaranteed funding with possible renewal in year 4) is intended to support early career investigators for the period between the completion of post-doctorate fellowship training and establishment as an independent investigator. Visit https://www.rheumresearch.org/career-development-research-awards#IA for more information.
Inquiries can be directed to:
Scientific: Mara Lennard Richard, PhD; mrichard@lupusresearch.org
Administrative: Diomaris Gonzalez; dgonzalez@lupusresearch.org
Empowering Lupus Research Administrative Supplement
The Lupus Research Alliance offers an Empowering Lupus Research Administrative Supplement (“ELR Supplement”) for promising trainees who reflect the communities and populations of people living with lupus and who are working with LRA-funded researchers or lupus investigators supported by the National Institutes of Health (NIH), Department of Defense (DOD), or equivalent grants in good standing.
Please see the 2025 Request for Applications for additional information and how to apply.
Inquiries can be directed to:
Scientific: Mara Lennard Richard, PhD; mrichard@lupusresearch.org
Administrative: Erin McLaughlin; emclaughlin@lupusresearch.org
Common Mechanisms in Autoimmunity
Breakthrough T1D (formerly JDRF), the Lupus Research Alliance, and the National Multiple Sclerosis Society have joined forces to identify common mechanisms of autoimmunity. These three leading autoimmune disease organizations are jointly funding research projects looking at common underlying disease mechanisms. Visit https://decodingautoimmunity.org/ for more information.
Inquiries can be directed to:
Maya Bader, PhD; mbader@lupusresearch.org
Lupus Insight Prize
The primary objective of the Lupus Insight Prize is to identify and recognize an outstanding investigator who has developed a novel research insight in scientific domains relevant to lupus. Click here for more information.
The 2025 deadline for this program has passed.
Inquiries can be directed to:
Scientific: Jenna Levy, PhD; jlevy@lupusresearch.org
Administrative: Erin McLaughlin; emclaughlin@lupusresearch.org
